Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTALAN

BUTABARBITAL SODIUM

Standard Dose
33.3MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview BUTALAN is listed in Drugs@FDA under application 085880 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BUTABARBITAL SODIUM Form and strength ELIXIR;ORAL - 33.3MG/5ML Sponsor LANNETT Submission history Latest submission status date: 2019-02-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUTALAN is listed in Drugs@FDA under application 085880 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BUTABARBITAL SODIUM Form and strength ELIXIR;ORAL - 33.3MG/5ML Sponsor LANNETT Submission history Latest submission status date: 2019-02-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.